Pharmarise Holdings CorporationJP:2796
Market cap
¥6.4B
P/E ratio
22.6x
| 2014/05 | 2015/05 | 2016/05 | 2017/05 | 2018/05 | 2019/05 | 2020/05 | 2021/05 | 2022/05 | 2023/05 | 2024/05 | 2025/05 | |
| Depreciation & amortization | 487 | 544 | 588 | 637 | 626 | 531 | 522 | 606 | 608 | 589 | 613 | 730 |
| Cash from operations | 1,306 | 3,405 | -273 | 2,103 | 1,330 | 895 | 1,572 | 1,945 | 713 | 2,520 | 2,714 | 1,311 |
| Capital expenditures | -827 | -619 | -466 | -563 | -403 | -400 | -349 | -508 | -379 | -380 | -472 | -637 |
| Cash from investing | -1,708 | -1,064 | -774 | -871 | -527 | -501 | -734 | -1,076 | -292 | -703 | -3,120 | -4,462 |
| Payments for dividends | -105 | -126 | -143 | -125 | -126 | -125 | -129 | -129 | -131 | -131 | -127 | -224 |
| Repurchases of common stock | - | - | - | - | - | - | -173 | -36 | -2 | - | -340 | - |
| Proceeds from issuance of term debt, net | 3,930 | 1,420 | 4,300 | 3,410 | 2,600 | 2,250 | 2,600 | 2,500 | 2,000 | 1,700 | 6,100 | 5,100 |
| Repayments of term debt | -3,162 | -2,975 | -2,978 | -3,658 | -2,999 | -2,960 | -2,675 | -2,729 | -2,609 | -2,419 | -2,358 | -3,716 |
| Cash from financing | 490 | -2,101 | 492 | -816 | -894 | 354 | -766 | -728 | -1,034 | -1,072 | 2,771 | 939 |